European white paper: oropharyngeal dysphagia in head and neck cancer.

Laura W J Baijens, Margaret Walshe, Leena-Maija Aaltonen, Christoph Arens, Reinie Cordier, Patrick Cras, Lise Crevier-Buchman, Chris Curtis, Wojciech Golusinski, Roganie Govender, Jesper Grau Eriksen, Kevin Hansen, Kate Heathcote, Markus M Hess, Sefik Hosal, Jens Peter Klussmann, C René Leemans, Denise MacCarthy, Beatrice Manduchi, Jean-Paul Marie, Reza Nouraei, Claire Parkes, Christina Pflug, Walmari Pilz, Julie Regan, Nathalie Rommel, Antonio Schindler, Annemie M W J Schols, Renee Speyer, Giovanni Succo, Irene Wessel, Anna C H Willemsen, Taner Yilmaz, Pere Clavé

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2021;278(2):577-616

PMID: 33341909

Abstract

PURPOSE

To develop a European White Paper document on oropharyngeal dysphagia (OD) in head and neck cancer (HNC). There are wide variations in the management of OD associated with HNC across Europe.

METHODS

Experts in the management of specific aspects of OD in HNC across Europe were delegated by their professional medical and multidisciplinary societies to contribute to this document. Evidence is based on systematic reviews, consensus-based position statements, and expert opinion.

RESULTS

Twenty-four sections on HNC-specific OD topics.

CONCLUSION

This European White Paper summarizes current best practice on management of OD in HNC, providing recommendations to support patients and health professionals. The body of literature and its level of evidence on diagnostics and treatment for OD in HNC remain poor. This is in the context of an expected increase in the prevalence of OD due to HNC in the near future. Contributing factors to increased prevalence include aging of our European population (including HNC patients) and an increase in human papillomavirus (HPV) related cancer, despite the introduction of HPV vaccination in various countries. We recommend timely implementation of OD screening in HNC patients while emphasizing the need for robust scientific research on the treatment of OD in HNC. Meanwhile, its management remains a challenge for European professional associations and policymakers.

Address: Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. [email protected].; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. [email protected].; Department of Clinical Speech and Language Studies, Trinity College Dublin, Dublin, Ireland.; Department of Otorhinolaryngology, Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg, Germany.; Department of Special Needs Education, University of Oslo, Oslo, Norway.; School of Occupational Therapy, Social Work and Speech Pathology, Curtin University, Perth, Australia.; Department of Neurology, Born Bunge Institute, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.; Voice, Speech, Swallowing Lab, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital UVSQ and Research lab CNRS-UMR7018, Hôpital Foch, Suresnes, France.; Swallows Head and Neck Cancer Charity, Blackpool, UK.; Department of Head and Neck Surgery, The Greater Poland Cancer Centre, Poznan University of Medical Sciences, Poznan, Poland.; Head and Neck Cancer Centre, University College London Hospital, London, UK.; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany.; Robert White Centre for Airway, Voice and Swallow, Poole Hospital NHS Foundation Trust, Dorset, UK.; Deutsche Stimmklinik, Hamburg, Germany.; Departement of Voice, Speech and Hearing Disorders, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine, Atılım University, Medicana International Ankara, Ankara, Turkey.; Department of Otolaryngology, Head and Neck Surgery, Amsterdam University Medical Centres, Vrije Universiteit, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam University Medical Centres, Vrije Universiteit, Amsterdam, The Netherlands.; Division of Restorative Dentistry and Periodontology, Faculty of Health Sciences, Trinity College Dublin, Dublin Dental University Hospital, Dublin, Ireland.; Department of Otorhinolaryngology, Head and Neck Surgery, Rouen University Hospital, Rouen, France.; Department of Ear Nose and Throat Surgery, The Robert White Centre for Airway Voice and Swallowing, Poole Hospital NHS Foundation Trust, University of Southampton, Southampton, UK.; Department of Speech and Language Therapy, St. James's Hospital, Dublin, Ireland.; Departement of Voice, Speech and Hearing Disorders, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.; MHeNs School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.; Department Neurosciences, Experimental Otorhinolaryngology, Deglutology, University of Leuven, Leuven, Belgium.; Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy.; Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Special Needs Education, University of Oslo, Oslo, Norway.; School of Occupational Therapy, Social Work and Speech Pathology, Curtin University, Perth, Australia.; Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Centre, Leiden, The Netherlands.; Faculty of Health, School of Health and Social Development, Victoria, Australia.; Head and Neck Oncology Service, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, TO, Italy.; Department of Oncology, University of Turin, Orbassano, TO, Italy.; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Hacettepe University, Ankara, Turkey.; Gastrointestinal Physiology Laboratory, Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.